Skip to content

PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk

PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk Using a Web-based Breast Cancer Screening Decision Aid Tool

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01879189
Enrollment
1302
Registered
2013-06-17
Start date
2013-09-30
Completion date
2017-11-30
Last updated
2018-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

In order to better communicate personal risk of breast cancer to women who have not yet initiated breast cancer screening (mammography), The Annenberg School of Communication at the University of Pennsylvania has created a personal breast cancer screening decision aid tool. This tool will be pilot tested, and then implemented and tested in nine primary care and OB/GYN practices within the University of Pennsylvania Health System.

Detailed description

In order to better communicate personal risk of breast cancer to women who have not yet initiated breast cancer screening (mammography), The Annenberg School of Communication at the University of Pennsylvania has created a personal breast cancer screening decision aid tool. This tool incorporates questions about a women's personal history of breast cancer and compares her to the average women her age in terms of breast cancer risk. The tool helps the women to understand the benefits and risks of breast cancer screening. This tool will be pilot tested using SSI to help develop the final version of the decision aid tool. The decision aid tool will then be implemented and tested in nine general internal medicine, family medicine, and OB/GYN practices within the University of Pennsylvania Health System.

Interventions

BEHAVIORALBreast Cancer Screening Decision Aid

The intervention will include access to the personal decision aid tool for patients in the intervention arm of the study, determined by the randomized physician schedule and the patient's appointment time.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
39 Years to 48 Years
Healthy volunteers
Yes

Inclusion criteria

* Women ages 39-48 * Patient of one of the nine primary care or OB/GYN practices that are participating in the study * Must have had an appointment at one of these locations in the past 24 months * Must have an appointment during the study period * Woman has not yet initiated breast cancer screening (no prior mammogram) * No history of breast cancer

Exclusion criteria

* Prior diagnosis of breast cancer * Major comorbidity that substantially affects their 10 year mortality * Non-English speaker

Design outcomes

Primary

MeasureTime frameDescription
Mammography Use Correlated to Personal Risk of Breast CancerOne year post-interventionMedical charts of women in both the intervention and control groups of the study will be analyzed to determine if these women initiated breast cancer screening (mammography) correlated to their personal risk of breast cancer as displayed by the decision aid.

Secondary

MeasureTime frameDescription
Knowledge, Worry, Regret, Decisional Conflict, Accuracy of Risk Perception6 weeks post-interventionSix weeks after a women's appointment with their primary care or OB/GYN provider, they will receive a post-intervention survey which will assess knowledge, worry, satisfaction, numeracy, behavior, etc.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026